Metabolic alteration in red blood cells from patients with community-acquired pneumonia

Dmitriy Klyuyev (Karaganda, Kazakhstan), Dmitiry Klyuyev, Larissa Muravyova, Vilen Molotov-Luchanskiy, Ryszhan Bakirova, Lyudmila Demidchik, Yevgenia Kolesnikova

Source: International Congress 2015 – Translational research in respiratory care: new findings
Session: Translational research in respiratory care: new findings
Session type: Thematic Poster Session
Number: 865
Disease area: Respiratory infections

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Dmitriy Klyuyev (Karaganda, Kazakhstan), Dmitiry Klyuyev, Larissa Muravyova, Vilen Molotov-Luchanskiy, Ryszhan Bakirova, Lyudmila Demidchik, Yevgenia Kolesnikova. Metabolic alteration in red blood cells from patients with community-acquired pneumonia. Eur Respir J 2015; 46: Suppl. 59, 865

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Biomarkers for oxidative stress in patients with community-acquired pneumonia
Source: International Congress 2015 – Prognostic factors in pneumonia: from clinical observations to experimental models
Year: 2015



Features of systemic inflammation in patients with severe community-acquired (CAP) pneumonia of different etiology in HIV-infected patients
Source: International Congress 2015 – Immunodepression and severe pneumonia
Year: 2015


Identification of extracellular nucleic acids and neutrophil extracellular traps in blood of patients with community-acquired pneumonia
Source: International Congress 2015 – Translational research in respiratory care: new findings
Year: 2015


Cardiac autonomic alterations impact early and late outcomes in patients with community-acquired pneumonia
Source: Annual Congress 2013 –Manifestations, scores and prognosis of community-acquired pneumonia
Year: 2013


Cardiovascular autonomic alterations and severity of the disease in community-acquired pneumonia
Source: Annual Congress 2013 –Manifestations, scores and prognosis of community-acquired pneumonia
Year: 2013


Procalcitonin as etiological marker of severe community-acquired pneumonia
Source: Annual Congress 2013 –Interesting cases of respiratory infections
Year: 2013


Dynamics of the etiological structure from sputum of patients with pneumonia
Source: Annual Congress 2013 –Manifestations, scores and prognosis of community-acquired pneumonia
Year: 2013

Community-acquired pneumonia in HIV-infected patients: The relevance of CD4+ cell count
Source: International Congress 2014 – Pathogenesis and mechanisms of respiratory infections
Year: 2014


Contribution of C-reactive protein to the diagnosis and assessment of severity of community-acquired pneumonia
Source: Annual Congress 2013 –Biomarkers, diagnosis and outcome of respiratory infections
Year: 2013


Clinical analysis of 32 cases of biopsy-proven secondary organizing pneumonia following community-acquired pneumonia
Source: International Congress 2014 – ILDs 4
Year: 2014

Clinical and laboratory predictors of survival in patients with severe community-acquired pneumonia (CAP)
Source: International Congress 2014 – Healthcare, prevention and adjunctive treatments in respiratory infections
Year: 2014


Late Breaking Abstract - Biomarkers for iron metabolism among patients hospitalized with community-acquired pneumonia caused by SARS-CoV-2, bacteria, and influenza
Source: Virtual Congress 2021 – Diagnosis and management of COVID-19
Year: 2021


Shortening duration of antibiotic therapy according to clinical stability in patients with community-acquired pneumonia (CAP)
Source: International Congress 2014 – Respiratory infections: inflammation and treatment
Year: 2014


Modern etiology of severe community-acquired pneumonia
Source: International Congress 2016 – Community-acquired pneumonia: risk classes and management issues
Year: 2016


Community acquired pneumonia in patients with ambulatory treatment. Etiology and evolution
Source: Annual Congress 2013 –Biomarkers, diagnosis and outcome of respiratory infections
Year: 2013


Biomarkers and community-adquired pneumonia (CAP) etiology
Source: Annual Congress 2012 - Prognostic indices in respiratory infections
Year: 2012


Predictive factors for true bacteremia and clinical utility of blood cultures as a prognostic tool in patients with community-onset pneumonia
Source: International Congress 2016 – Community-acquired pneumonia: risk classes and management issues
Year: 2016

Metabolomic analysis of infectious parapneumonic effusions reveals biomarkers for management of children with streptococcus pneumoniae pneumonia
Source: International Congress 2016 – Paediatric respiratory infection and immunology
Year: 2016

Role of procalcitonin in predicting severity and in-hospital mortality in patients with community-acquired pneumonia
Source: International Congress 2016 – Community-acquired pneumonia: risk classes and management issues
Year: 2016


Respiratory pathogens, immunodeficiency or systemic response – What comes first in the etiology of severe community-acquired pneumonia (sCAP)
Source: Annual Congress 2013 –Biomarkers, diagnosis and outcome of respiratory infections
Year: 2013